1. Report Introduction 2. Brain Metastasis - Disease Overview 3. Pipeline Outlook • An Overview of Pipeline Products for Brain Metastasis 4. Comparative Analysis 5. Brain Metastasis Therapeutic Products in Clinical Stage 5.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities Other product profiles in the detailed report….. 6. Brain Metastasis Therapeutic Products in Non-clinical Stage 6.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities Other product profiles in the detailed report….. 7. Therapeutic Pipeline Analysis • Pipeline Analysis by Route of Administration • Pipeline Analysis by Stage and Route of Administration • Pipeline Analysis by Molecule Type • Pipeline Analysis by Stage and Molecule Type 8. Inactive Pipeline Products 8.1 Drug Description • Research and Development Studies • Product Development Activities • Reason for dormancy/discontinuation Appendix Report Methodology Consulting Services Disclaimer About DelveInsight Note: Certain sections of the table of contents would vary according to the availability of information

Table 1: Total Pipeline Products for Brain Metastasis Table 2: Brain Metastasis Therapeutic Products in Clinical Stage Table 3: Brain Metastasis Therapeutic Products in Non-clinical Stage Table 4: Pipeline Analysis by Route of Administration Table 5: Pipeline Analysis by Stage and Route of Administration Table 6: Pipeline Analysis by Molecule Type Table 7: Pipeline Analysis by Stage and Molecule Type Table 8: Inactive Products Figure 1: Total Products for Brain Metastasis Figure 2: Brain Metastasis Therapeutic Products in Clinical Stage Figure 3: Brain Metastasis Therapeutic Products in Non-clinical Stage Figure 4: Pipeline Analysis by Route of Administration Figure 5: Pipeline Analysis by Stage and Route of Administration Figure 6: Pipeline Analysis by Molecule Type Figure 7: Pipeline Analysis by Stage and Molecule Type Figure 8: Inactive Products